dipyridamole has been researched along with acivicin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Alberti, D; Bruggink, J; Earhart, RH; Fischer, PH; Hamilton, RD; Koeller, JM; Simon, K; Tormey, DC; Tutsch, K; Willson, JK | 1 |
Bruggink, J; Fischer, PH; Ranhosky, A; Risueno, C; Trump, DL; Tutsch, K; Willson, JK | 1 |
Faderan, MA; Lui, MS; Natsumeda, Y; Weber, G | 1 |
Bittner, G; Fischer, PH; Pamukcu, R; Willson, JK | 1 |
Lui, MS; Weber, G; Zhen, YS | 1 |
7 other study(ies) available for dipyridamole and acivicin
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Dipyridamole; Drug Evaluation; Humans; Isoxazoles; Leukocyte Count; Metabolic Clearance Rate; Neoplasms; Nucleosides | 1988 |
Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon-Nitrogen Ligases; Dipyridamole; Drug Evaluation; Humans; Infusions, Intravenous; Isoxazoles; Ligases; Nucleosides | 1988 |
Salvage capacity of hepatoma 3924A and action of dipyridamole.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cells, Cultured; Dipyridamole; Drug Synergism; Guanine Deaminase; Hypoxanthine Phosphoribosyltransferase; Isoxazoles; Liver; Liver Neoplasms, Experimental; Pentosyltransferases; Purine Nucleotides; Pyrimidines; Rats; Xanthine Oxidase | 1983 |
Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
Topics: Antibiotics, Antineoplastic; Cell Cycle; Cell Line; Cell Survival; Colonic Neoplasms; Dipyridamole; Humans; Isoxazoles; Kinetics; Oxazoles; Ribonucleosides; Ribonucleotides | 1984 |
Effects of acivicin and dipyridamole on hepatoma 3924A cells.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Dipyridamole; Isoxazoles; Kinetics; Liver Neoplasms, Experimental; Oxazoles; Rats; Ribonucleosides | 1983 |